Company Overview and News

140
Merger Arbitrage Mondays - July 16, 2018

2018-07-16 seekingalpha
DOJ's challenge to AT&T and Time Warner’s merger could affect the bidding war between Disney and Comcast for Twenty-First Century Fox.
FOX STDY CMCSA RAD TWX CALL SXE GGP TWC FOXA

139
My 'Ten Commandments' Of Investing

2018-07-11 seekingalpha
In this letter, I wish to share with you our investment strategy and summarize for you the logic behind our investment activities.
BAMGF NNUTU NNUTD CALL RAD AGO BAMKF BAM

138
Merger Arbitrage Mondays - July 9, 2018

2018-07-09 seekingalpha
Perry Ellis International (PERY) confirmed receipt of a non-binding, unsolicited proposal from privately-held Randa Accessories Leather Goods.
MAT STDY RAD CALL GGP SXE

4
magicJack VocalTec Ltd. Announces Receipt of ITA Withholding Tax Ruling Related to Pending Acquisition by B. Riley

2018-06-28 globenewswire
WEST PALM BEACH, Fla. and NETANYA, Israel, June 28, 2018 (GLOBE NEWSWIRE) -- magicJack VocalTec Ltd. (“magicJack”) (NASDAQ:CALL), a leading Voice over IP (VOIP) cloud-based communications company, announced today that it has received from the Israel Tax Authority (“ITA”) the “Withholding Tax Ruling” contemplated by the merger agreement among magicJack, B. Riley Financial, Inc. and B. R. Acquisition Ltd.
CALL

222
Merger Arbitrage Mondays - June 18, 2018

2018-06-19 seekingalpha
Merger activity increased last week with two new deals announced and five pending deals closing. Several deals with large spreads on account of regulatory hurdles including Bayer's acquisition of Monsanto, AT&T's (NYSE:T) acquisition of Time Warner and China Oceanwide's acquisition of Genworth (NYSE:GNW) recently managed to get past those hurdles.
CAVM MRVL STDY RAD TWX NXPI WGL SXE MCHP TWC MSCC T CALL GNW QCOM GGP

54
Kanen Files Preliminary Proxy Materials for the Election of Its Slate of Highly Qualified Directors at Aqua Metals' Upcoming 2018 Annual Meeting

2018-04-11 accesswire
-Believes It is Critical for Aqua Metals to Immediately Retain a Credible and Qualified Interim CEO and Strongly Recommends Former Chief Commercial Officer Steve Cotton for This Role -Highlights Serious Concerns about the Company's Significant Underperformance and Poor Corporate Governance Practices -Reiterates Desire to Work Constructively with Aqua Metals to Reconstitute the Board, But Beliefs Substantial Change is Required to Reverse the Recent, Drastic Underperformance and Fix the Company's Governance
RSYS QBAK CTXAY ABCO UBNZF DAIO UBN CTX FTV S CVX CALL CTXAF INTC AQMS

40
Kanen Nominates Slate Of Four Highly Qualified Director Candidates For Election At Aqua Metals' 2018 Annual Meeting

2018-03-26 accesswire
Believes Substantial Board Change Is Required to Reverse Years of Underperformance and Improve Operating Performance and Unlock Value
RSYS QBAK FTV S CALL INTC UBNZF DAIO AQMS UBN

4
CALL / magicJack VocalTec Ltd. DEFA-14A

2018-03-13 sec.gov
UNITED STATES
CALL

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to CALL / magicJack VocalTec Ltd. on message board site Silicon Investor.

For the Psychologically Oriented Stock calls for fun - take this seriously at your risk
Calls and Puts for Income Callaway Golf -- itu0027s a buy
Calling all SI Poets Covered Calls For Income Production
Magic Jack = CALL Articles or research on possible company takeovers
Magic Jack The Covered Calls for Dummies Thread
CUSIP: M6787E101